Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as a Distinguished provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Dr. Debraj “Raj” Mukherjee’s clinical focus is the treatment of patients with primary and metastatic brain lesions. His clinical work and research emphasize the development of individual treatment plans that optimize survival and quality of life in all patients. After receiving his medical degree from Dartmouth Medical School, Dr. Mukherjee was recruited to Johns Hopkins, where he studied epidemiology, biostatistics and clinical design at the Johns Hopkins Bloomberg School of Public Health and served as Director of the Neuro-Oncology Surgical Outcomes Laboratory in the Department of Neurosurgery. Dr. Mukherjee completed neurosurgery residency at Cedars-Sinai Medical Center, where he was named a Robert Wood Johnson Foundation Health & Society Scholar. He completed an open and endoscopic skull base fellowship with the Center for Skull Base Surgery at University of Pittsburgh Medical Center, where he was a Copeland Scholar. Throughout his career, Dr. Mukherjee has led patient-centered research pursuits in neuro-oncology including development of a national registry for patients with brain tumors, creation of disease-specific quality of life instruments for patients with skull base tumors, and development of innovative clinical trials in neuro-oncology. He leads the Meningioma, Brain Metastasis, and Neurosurgical Oncology centers at Johns Hopkins Medicine, and he serves as Assistant Residency Program Director for one of the largest neurosurgical training programs in the country. His work has been supported by the American Medical Association, Glioblastoma Foundation, National Institute on Aging, and National Cancer Institute. Dr. Mukherjee can be contacted at drraj@jhmi.edu. Dr. Mukherjee is rated as a Distinguished provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Tumor, Awake Craniotomy, and Laminectomy.

Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure. Dr. Jackson is rated as an Advanced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Hydrocephalus, Chiari Malformation, Chiari Malformation Type 2, Posterior Fossa Decompression, and Endoscopy.

Dr. Watkins received a bachelor of arts degree in Psychobiology from Harvard University and a medical doctor degree from the University of Chicago-Pritzker School of Medicine. She completed internship at Georgetown-INOVA Fairfax Hospital followed by a Diagnostic Radiology residency and Neuroradiology fellowship at Johns Hopkins Hospital. Prior to joining Johns Hopkins, Dr. Watkins was a staff Neuroradiologist for Johns Hopkins Howard County Medical Center and the director of the Bethesda outpatient center for American Radiology from 2006-2015. She then served as Sub Chief of Neuroradiology Mid Atlantic Permanente Medical Group from 2015-2016. Dr. Watkins has served as a Neuroradiology course lecturer for the American College of Radiology, case review lecturer for the Radiological Society of North America and a reviewer for the Neuroradiology section of the Radiographics Journal. Dr. Watkins is rated as an Advanced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Stroke, Subarachnoid Hemorrhage, Meningioma, and Craniopharyngioma.

Dr. Jon Weingart focuses on the surgical treatment of brain tumors including benign and malignant tumors. Dr. Weingart also specializes in spinal disorders, such as cervical and lumbar disc disease, as well as other congenital and developmental abnormalities such as tethered spinal cord, spina bifida and chiari malformation. Dr. Weingart is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Osteotomy.

Sahaja Acharya is the Director of Pediatric Radiation Oncology within the Department of Radiation Oncology and Molecular Radiation Sciences. She specializes in pediatric brain tumors, pediatric sarcomas, and adult sarcomas. She is also the Associate Director for the Radiation Oncology Residency Program. She leads the Pediatric Radiation Oncology program at the Johns Hopkins Hospital and treats patients at both Johns Hopkins Hospital and Sibley Memorial Hospital. She has extensive expertise in proton therapy, SBRT, pediatric malignancies, and adult sarcoma. She is the Principal Investigator on external grants from ASCO Conquer Cancer, the Department of Defense, and the Carson Leslie Foundation. She is also the Principal Investigator of phase II pediatric brain tumor clinical trials. She has been invited to participate in multiple national and international guideline committees and regularly lectures on pediatric malignancies and proton therapy. Dr. Acharya received her Bachelor's in Chemistry and Political Science from Stanford University and her medical degree from Saint Louis University. She completed radiation oncology residency at Washington University in St. Louis. Dr. Acharya is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Brain Tumor, Gliomatosis Cerebri, Glioma, and Posterior Fossa Tumor.

Alan R. Cohen is the director of pediatric neurosurgery at Johns Hopkins Children’s Center in Baltimore, Maryland, and one of the top pediatric neurosurgeons in the country. His area of specialty is treating infants and children diagnosed with brain tumors. Dr. Cohen’s goal is to get his patients back to being a kid again. He has a patient-centered approach to caring for each of his patients, working closely with the child’s family at every stage of the decision-making process. Dr. Cohen sees patients in the neurosciences clinic located in the Levi Watkins, Jr., M.D., Outpatient Center. As the Carson-Spiro Professor of Pediatric Neurosurgery, Dr. Cohen is a leader in developing minimally invasive techniques to enhance the safety and efficacy of selected pediatric neurosurgical procedures. He serves as director of the Minimally Invasive Neurosurgery Laboratory at Johns Hopkins and directs the Minimally Invasive Neurosurgery Fellowship Program. His lab focuses on developing novel instruments and surgical approaches. He has authored more than 200 peer-reviewed journal articles and book chapters, and published two textbooks. He has given approximately 330 national and international presentations, and has been an invited visiting professor at 50 medical centers. He is past president of the Society of Neurological Surgeons, the American Society of Pediatric Neurosurgeons and the AANS/CNS Section on Pediatric Neurological Surgery. He is past vice president of the American Academy of Neurological Surgery, a past director of the American Board of Neurological Surgery and current director of the American Board of Pediatric Neurological Surgery. Patient Reviews Hear what patients have to say about Dr. Cohen’s care: • Healthgrades Patient Reviews • Vitals Patient Reviews. Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Arachnoid Cysts, Meningocele, Hydrocephalus, Endoscopy, and Cerebral Artery Bypass Surgery.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

Dr. Haris Sair is Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, and the Director of the Division of Neuroradiology. His areas of clinical expertise include functional Magnetic Resonance Imaging (fMRI) of the brain. He also has a faculty appointment in the Malone Center for Engineering in Healthcare at The Whiting School of Engineering, Johns Hopkins University, investigating the use of machine learning and artificial intelligence in imaging. He is a founding director of the Radiology Artificial Intelligence Lab (RAIL). He previously served as the President of the American Society of Functional Neuroradiology. Dr. Sair earned his M.D. from Duke University School of Medicine. He completed his Radiology residency at Temple University Medical Center, and fellowship in Neuroradiology at Massachusetts General Hospital in Boston, MA. Dr. Sair is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Traumatic Brain Injury, Cerebrospinal Fluid Leak, and Microvascular Decompression.

Dr. Gary Wand is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in psychiatry and behavioral sciences. His areas of clinical expertise include endocrinology, neuroendocrine disorders and pituitary disorders. Dr. Wand serves as the director of the fellowship program and the director of the endocrine training program at the Johns Hopkins School of Medicine. Dr. Wand earned his M.D. and completed his residency at the George Washington University School of Medicine. He performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include the neurobiology of substance abuse and the physiogenetics of the stress response. Dr. Wand has been recognized in “Best Doctors in America” and is a recipient of the National Institutes of Health Merit Award. Dr. Wand is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Pituitary Tumor, Prolactinoma, Cushing's syndrome, and Hypogonadotropic Hypogonadism.

Dr. Doris Da May Lin is an Associate Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She specializes in neuroradiology. Dr. Lin received her B.A. in chemistry from the University of Pennsylvania, and then pursued a joint M.D./Ph.D. degree at the Yale University School of Medicine, with graduate training in the neurosciences. She completed a medical internship at the University of Pennsylvania Hospital and a diagnostic radiology residency at New York Presbyterian Hospital-Cornell. After a two-year neuroradiology fellowship, she joined the faculty at Johns Hopkins. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Parkes Weber Syndrome, Sturge-Weber Syndrome, Subdural Effusion, CACH Syndrome, and Endovascular Embolization.

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as an Advanced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Roberto Salvatori is an Endocrinologist in Baltimore, Maryland. Dr. Salvatori is rated as an Advanced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Growth Hormone Deficiency (GHD), Hypopituitarism, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT).

Aldo Londino is a Pediatric Otolaryngologist and an Otolaryngologist in Baltimore, Maryland. Dr. Londino is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Enlarged Adenoids, Laryngomalacia, Otitis, and Stridor.

Andrea Hebert is an Otolaryngologist in Baltimore, Maryland. Dr. Hebert is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. Her top areas of expertise are Low Nasal Bridge, Nasal Septal Hematoma, Perichondritis, Turbinectomy, and Septoplasty. Dr. Hebert is currently accepting new patients.

Joseph Simard is a Neurosurgery provider in Baltimore, Maryland. Dr. Simard is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Wyburn-Mason Syndrome, Vein of Galen Aneurysm, Arteriovenous Malformation, Gastrostomy, and Carotid Artery Surgery.

Haroon Ahmad is a Neurologist in Baltimore, Maryland. Dr. Ahmad is rated as an Experienced provider by MediFind in the treatment of Craniopharyngioma. His top areas of expertise are Oligodendroglioma, Glioma, Astrocytoma, and Glioblastoma.